SEBI has issued an ex-parte interim order against Copthall Mauritius Investment Ltd and Mansi Share and Stock Broking Ltd for allegedly manipulating the Closing Auction System on the BSE. The regulator has impounded ₹3.68 crore in wrongful gains and restricted both entities from participating in the auction window.

The Securities and Exchange Board of India (SEBI) has taken its first enforcement action under the newly introduced Closing Auction System (CAS), passing an ex-parte interim order against Copthall Mauritius Investment Ltd, an affiliate of JP Morgan Chase, and Mansi Share and Stock Broking Ltd. The regulator alleges that aggressive orders in Sensex constituents were used to influence the index's closing level to generate gains in expiry-day options.

SEBI introduced the CAS mechanism in a phased manner starting August 3, 2026, to make the stock closing price mechanism more transparent and align it with global practices. Under this framework, normal trading halts at 3:15 pm, a reference price is calculated by 3:20 pm, and an auction runs until a random closure between 3:28 pm and 3:30 pm. Prices of Sensex constituents are allowed to move up to 3 per cent from the reference price during this window before a single equilibrium price is discovered by 3:35 pm.

The alleged manipulation took place on August 13, the weekly expiry day for Sensex derivatives, when the mechanism was barely two weeks old. According to SEBI's surveillance, the Sensex reference price was 77,829.60, but the index eventually closed at 78,080 after experiencing three sharp, short-lived spikes during the auction window. Copthall was identified as the dominant buyer during these upward movements, placing large limit-buy orders at 3 per cent above the reference price across all Sensex constituents. SEBI noted that Copthall held outstanding long call and short put positions in Sensex options, which benefited from the pushed-up index.

Meanwhile, Mansi Share and Stock Broking followed a different approach. SEBI stated that the stock broker's orders suppressed the Sensex Indicative Equilibrium Price (IEP) for around four to five minutes through aggressive selling in eight constituents. After squaring off its open Sensex put options to its advantage, the broker cancelled the sell orders. SEBI noted that while both entities influenced the IEP to benefit their respective derivatives positions, the evidence does not prima facie indicate that they acted in concert.

In response to the violations, SEBI has impounded prima facie wrongful gains of ₹2.96 crore for Copthall and ₹71.65 lakh for Mansi, totaling ₹3.68 crore, to be placed in fixed deposits with a lien in SEBI's favour. Both entities have been prohibited from participating in the CAS in the equity segment and restrained from accessing the securities market more broadly. SEBI stated that immediate directions were necessary because both entities had already built outstanding positions in the subsequent weekly Sensex options contract expiring on August 20.

The interim order was signed by whole-time member Kamlesh Chandra Varshney. Both Copthall and Mansi Share and Stock Broking have 21 days to file replies and objections and may seek a personal hearing. SEBI Chairperson Tuhin Kanta Pandey had earlier warned that any attempts to manipulate the CAS framework would be dealt with sternly, emphasizing that the regulator's ability to catch manipulation under CAS is higher than the older volume-weighted average price system.

"This enforcement action highlights the critical importance of regulatory compliance and surveillance in newly introduced market mechanisms. As SEBI ramps up its oversight on derivative trading and price discovery frameworks like the Closing Auction System, institutional participants must exercise rigorous internal controls. Regulatory vigilance on expiry-day positioning ensures market integrity, signaling that aggressive manipulation of closing prices will face swift and stringent intervention." — Dr. Shishir Gupta, Founder & CEO, StartupLanes

Recent StartupLanes Articles

Browse through our 30 latest publications on venture capital, startups, and angel investing.

MCX Copper Futures Decline From Recent Highs as Market Approaches Key Support Levels Oct 22, 2026
OpenAI Acquires Orchestra Bio to Expand Life Sciences and Drug Development Capabilities Oct 22, 2026
Dr. Reddy’s Laboratories Receives DCGI Approval for Toripalimab in India Oct 22, 2026
Anthropic's Confidential IPO Filing Reveals $80.7 Billion H1 Loss and Heavy Computing Costs Oct 22, 2026
Jio Platforms Launches ₹30,213 Crore IPO: Key Details, Valuations, and Brokerage Views Oct 22, 2026
State Bank of India Reports Suspected Customer Data Exposure on Dark Web Oct 22, 2026
US Secretary of State Marco Rubio Terms Envoy Meeting with Ukrainian President Positive Oct 22, 2026
Rupee Strengthens 29 Paise Against US Dollar in Early Trade, Supported by RBI and Jio IPO Inflows Oct 22, 2026
Brent Crude Stays Above $110 Amid West Asia Supply Concerns and Inventory Data Oct 22, 2026
Indian Market Updates: Corporate Earnings, Strategic Agreements, and Expansion Plans Across Sectors Oct 22, 2026
Corporate Updates: Infosys Expands Truist Collaboration, Cemindia Raises ₹1,400 Crore via QIP, and Multiple Firms Report Contracts and Acquisitions Oct 22, 2026
Centre to Review National Mineral Policy 2019 to Focus on Critical Minerals and Deep-Sea Resources Oct 22, 2026
Qualcomm Announces Global Job Cuts Following Annual Performance Reviews Oct 22, 2026
AstraZeneca Pharma Relocates Registered Office from Karnataka to Maharashtra Oct 22, 2026
Hindusthan National Glass Plans Up to ₹500 Crore Investment to Scale Manufacturing Capacity Oct 21, 2026